Suppr超能文献

亚铁离子是心肌肌浆网中兰尼碱受体敏感钙通道的调节剂。

Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum.

作者信息

Kim E, Giri S N, Pessah I N

机构信息

Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis 95616.

出版信息

Toxicol Appl Pharmacol. 1995 Jan;130(1):57-66. doi: 10.1006/taap.1995.1008.

Abstract

Iron is examined for its ability to modify Ca2+ transport across sarcoplasmic reticulum (SR) and to alter the binding of [3H]ryanodine to its high-affinity site on the Ca2+ release channel complex of SR preparations from rat heart. Iron(III) (added as ferric chloride) has negligible activity on active Ca2+ accumulation into SR and on the binding of [3H]ryanodine. In contrast, Fe(II) (added as ferrous sulfate) is a potent inhibitor of both Ca(2+)-induced Ca2+ release (IC50 of 29 microM) and DXR-induced Ca2+ release (IC50 of 14 microM). Iron(II) enhances the rate of active Ca2+ uptake into SR vesicles, mimicking the actions of the known SR Ca2+ channel blocker ruthenium red. The underlying mechanism of Fe(II) on SR Ca2+ transport is shown to be a direct and potent action on the ryanodine receptor. Fe(II) inhibits the binding of [3H]ryanodine when assayed in the presence of 5 microM Ca2+ with an IC50 of 4 microM and in an apparently cooperative manner (nH = 1.7). In the presence of physiological (1 mM) Mg2+, Fe(II) decreases the sensitivity of ryanodine receptors toward activation by Ca2+ shifting EC50 from 18 to 35 microM in the absence and presence of 5 microM Fe(II), respectively, without significant decrease in maximum [3H]ryanodine occupancy. In the presence of 5 microM Ca2+ and 1 mM Mg2+, Fe(II) decreases the potency of doxorubicin (DXR) on [3H]ryanodine binding (shifts EC50 from 8 to 24 microM in the absence and presence of 5 microM Fe(II)). These results suggest that Fe(II) competes with Ca2+ at the activator sites on the channel complex. The actions of Fe(II) on ryanodine receptor function is not correlated with membrane lipid peroxidation of SR vesicles since Fe(II) does not produce detectable changes in malondialdehyde using the thiobarbituric acid assay. These results demonstrate a direct inhibition of the Ca2+ release channel of cardiac SR by Fe(II) which may be important in pathological states of the heart during iron overload.

摘要

研究了铁改变钙离子跨肌浆网(SR)转运的能力,以及铁对[3H]ryanodine与其在大鼠心脏SR制剂的钙离子释放通道复合体上高亲和力位点结合的影响。三价铁(以氯化铁形式添加)对钙离子主动蓄积进入SR以及[3H]ryanodine的结合活性可忽略不计。相比之下,二价铁(以硫酸亚铁形式添加)是钙离子诱导的钙离子释放(IC50为29微摩尔)和柔红霉素诱导的钙离子释放(IC50为14微摩尔)的强效抑制剂。二价铁提高了钙离子主动摄取进入SR囊泡的速率,模拟了已知的SR钙离子通道阻滞剂钌红的作用。结果表明,二价铁对SR钙离子转运的潜在机制是对ryanodine受体有直接且强效的作用。当在5微摩尔钙离子存在下进行检测时,二价铁抑制[3H]ryanodine的结合,IC50为4微摩尔,且呈明显的协同作用(nH = 1.7)。在生理浓度(1毫摩尔)镁离子存在下,二价铁降低了ryanodine受体对钙离子激活的敏感性,在不存在和存在5微摩尔二价铁时,EC50分别从18微摩尔变为35微摩尔,而最大[3H]ryanodine占有率无显著降低。在5微摩尔钙离子和1毫摩尔镁离子存在下,二价铁降低了阿霉素(DXR)对[3H]ryanodine结合的效力(在不存在和存在5微摩尔二价铁时,EC50分别从8微摩尔变为24微摩尔)。这些结果表明,二价铁在通道复合体的激活位点与钙离子竞争。二价铁对ryanodine受体功能的作用与SR囊泡膜脂质过氧化无关,因为使用硫代巴比妥酸测定法时,二价铁未引起丙二醛的可检测变化。这些结果表明,二价铁对心脏SR的钙离子释放通道有直接抑制作用,这在铁过载时心脏的病理状态中可能很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验